SCHEMBL1024159

SCHEMBL1024159

CCCCC(CC)CC(C)(C)CC(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
CYP3A4 P08684 4/20 0.43
TSHR P16473 3/20 0.43
CA2 P00918 7/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ATM Q13315 1/20 0.34
MAPK1 P28482 1/20 0.33
CA1 P00915 3/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
CHRM1 P11229 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
OPRM1 P35372 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359408 0.84 ALDH1A1 (0.42) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL28241103 0.83 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL28528678 0.81 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL3623130 0.79 ALDH1A1 (0.56) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL19091741 0.78 ALDH1A1 (0.52) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL28528679 0.77 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL3971932 0.76 ALDH1A1 (0.42) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL28954698 0.74 ALDH1A1 (0.37) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL17607476 0.74 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL8528915 0.74 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846065-B2 Ester mixtures and compositions comprising such ester mixtures COGNIS IP MANAGEMENT GMBH (DE) 2014-09-30 US disclosed
US-20120115949-A1 Ester Mixtures And Compositions Comprising Such Ester Mixtures COGNIS IP MANAGEMENT GMBH (DE) 2012-05-10 US disclosed
EP-2448550-A1 ESTER MIXTURES AND COMPOSITIONS COMPRISING SUCH ESTER MIXTURES Cognis IP Management GmbH (DE) 2012-05-09 EP disclosed
WO-2011000487-A1 ESTER MIXTURES AND COMPOSITIONS COMPRISING SUCH ESTER MIXTURES COGNIS IP MANAGEMENT GMBH (DE) 2011-01-06 WO disclosed
EP-2269566-A1 Ester mixtures and compositions comprising such ester mixtures Cognis IP Management GmbH (DE) 2011-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115949-A1 Ester Mixtures And Compositions Comprising Such Ester Mixtures CES1, CETP, CES2 ALDH1A1 129/4885TDP1 1861/4885CYP3A4 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.